Skip to main content
. 2015 May 1;33(4):881–889. doi: 10.1007/s10637-015-0243-5

Fig. 2.

Fig. 2

Ipilimumab serum concentration profile versus time during Cycle 3. Open circles, ipilimumab 3 mg/kg plus PTX/CBDCA group (n = 6); closed circles, ipilimumab 10 mg/kg plus PTX/CBDCA group (n = 6). Data are mean plus standard deviation. On Day 1 of Cycle 3, blood serum samples were drawn at the following time points: Pre-infusion, 1.5 h (just prior to the end of ipilimumab dosing), 4 h and 24 h